Navigation Links
X-Change Corp. Delighted with DOJ's Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees 'Green Light' for Company's Patient-Driven Medical Cannabis Operations Under State Laws
Date:8/30/2013

COLORADO SPRINGS, Colo., Aug. 30, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing primarily in cannabinoid formulation-based health and wellness solutions, is pleased that the DOJ has provided broad and historic guidance to all federal authorities to defer to states' cannabis laws and regulations, including not challenging general legalization laws in Colorado and Washington State.  Federal action is sanctioned in specific circumstances, such as in preventing violence and use of firearms, distribution to minors, poor state regulatory systems, and cultivation on federal lands.  The impact of yesterday's announcement by the Deputy Attorney General, James M. Cole, is groundbreaking and will inevitably result in enhanced markets that benefit physicians and patients seeking cannabinoid-based treatments in the nearly two dozen states and jurisdictions that have enacted medical cannabis laws.  This federal guidance also points other states to a clear pathway to legalizing medical cannabis without concern for undue federal interference, which will give patients unprecedented treatment opportunities throughout the country.

Importantly, medical cannabis companies, such as X-Change Corp., will not be penalized for success in the medical cannabis market, as the DOJ ended uncertainty about enforcement distinctions based on commercial size and for-profit status.  Working within state regulatory regimes, the new federal policy allows X-Change Corp. to more confidently and efficiently manage logistical operations, supply chains, research and development efforts, and other commercial variables that produce economies of scale and better, more cost effective products and services.  The new legal landscape will also permit the Company to better utilize our expert management and development team in both Europe and North America.

"Progress in the acceptance of medical cannabis has now, I believe, reached the tipping point in the United States.  The federal government has taken a long-awaited, critical leap forward to catch up with the reasoned and compassionate actions of individual states and their citizens.  X-Change Corp. is incredibly heartened by these federal developments and intends to continue to forge ahead with its multi-pronged business plan, including the management and operation of patient-driven medical cannabis facilities in legal and robust state regulatory environments throughout the country," stated Chad S. Johnson, COO and General Counsel of The X-Change Corporation.

This announcement comes less than two weeks before a September hearing by the Senate Judiciary Committee, at which Committee Chair Patrick Leahy stated he will address the blurred lines between federal and state cannabis laws.  Among those to testify at the hearing is the Deputy Attorney General who authored the DOJ's guidance memorandum.  The DOJ announcement also closely follows the well-received documentary and pro-medical cannabis editorial in which renowned neurosurgeon Dr. Sanjay Gupta, Chief Medical Correspondent of CNN, brought to the world stage the real life stories of medical cannabis patients after nearly a year of research on the subject.

Deputy Attorney General James M. Cole's August 29, 2013 Memorandum For All United States Attorneys, "Guidance Regarding Marijuana Enforcement", can be found here. http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf

The Roll Call article on the medical cannabis Senate Judiciary Committee hearing, scheduled for September 10, 2013, can be found here. http://blogs.rollcall.com/wgdb/leahy-schedules-marijuana-hearing-wants-state-laws-respected/

CNN's Dr. Sanjay Gupta's pro-medical cannabis editorial can be found here. http://www.cnn.com/2013/08/08/health/gupta-changed-mind-marijuana

About The X-Change Corporation
The X-Change Corporation is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, The X-Change Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

X-Change Corp.
Dr. Dorothy Bray, President
Mr. Chad S. Johnson, Esq., COO & General Counsel
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595

Investment Inquiries
Mr. Robert Kane, CFO, Sr Vp of Business Development
rkane@xchangecorp.com
+1.561.420.4824


'/>"/>
SOURCE The X-Change Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
2. Medbox Signs Multi-State Consulting Deal with X-Change Corporation
3. X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting
4. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
5. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
6. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
7. ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
8. Millennium Surgical Corp. Announces Sales Figures, Growth
9. Millennium Surgical Corp. Develops Online Sterilization Resource Center
10. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
11. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior ... executive officer, today. In his new role, Marziani will lead the company,s business development ... professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
(Date:5/24/2016)... -- Open Access Journal Focusing on ... Elsevier , a world-leading provider of scientific, technical ... launch of Clinical Neurophysiology Practice ... clinical practice issues in clinical neurophysiology. The journal will ... and didactic reviews. It is an official journal of ...
Breaking Medicine Technology:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... this installment is bolstered by inspiring human interest stories, courtesy of leaders in ... trends and tech within the industry, from leading advocates and associations—namely Jones & ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare ... suppliers for its inaugural Member Conference at the Paris Hotel in Las Vegas, ... operational health of America’s healthcare providers. , The conference was highlighted by the ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... to support the company’s continued investment and strategic growth plans in the Asia ...
Breaking Medicine News(10 mins):